Pfizer tops in U.K. research linkups; India's Torrent wraps up Zyg buy;

@FiercePharma: We've got a brand new special report today! Top 10 pharma companies in social media. Feature | Follow @FiercePharma

@EricPFierce: ICYMI: Gallant Pharma owner notified in jail by FDA he is disbarred for life from the pharma industry. More from PharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Baxalta tots up winning hemophilia data as new med beats Advate in late-stage trial. More from FiercePharmaMarketing | Follow @CarlyHFierce

> Pfizer ($PFE), which stirred up a big political controversy in the U.K. when it tried to buy AstraZeneca ($AZN) last year, was ranked the top foreign research partner in the country in a new government report. Article

> India's Torrent Pharmaceuticals wrapped up its buyout of the dermatology drug specialist Zyg Pharma. Report

> GlaxoSmithKline ($GSK) said it's hard at work combating counterfeit drugs in Nigeria, where the company has a consumer healthcare partnership with pharmacists. Report

> Demand for over-the counter drugs in the U.K. jumped by 6.7% in the 12 months ended in February, a change experts linked partly to the National Health Service's emphasis on patient self-care. Report

Medical Device News

@FierceMedDev: Illumina launches new lab service for HiSeq X sequencing systems. FierceDiagnostics article | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Study finds Philips' ventilator helps reduce hospital readmissions for COPD. Article | Follow @VarunSaxena2

@EmilyWFierce: In 10 years, liquid biopsy test for cancer will be part of routine annual exams, says Guardant Health CEO. More from the WSJ | Follow @EmilyWFierce

> Hospitals launch trial to test AliveCor's iPhone-enabled ECG for diagnosis of heart attacks. Report

> Early study results indicate EndoStim's implant is effective for treating acid reflux. Story

> Stryker to buy Turkish partner in its second hospital bed acquisition in 2015. More

> NIH-backed scientists develop wireless, remote-controlled brain implant. Article

Biotech News

@FierceBiotech: Bristol-Myers flags an early success for PhIII Opdivo study. Article | Follow @FierceBiotech

@JohnCFierce: Americans want Medicare to negotiate lower drug prices -- (one day it's going to come). More from Reuters | Follow @JohnCFierce

> Tekmira changes its name and shuffles away from Ebola. News

> Agenus bags cancer antibodies in $44M deal. More

> Another Alzheimer's upstart swings for a $150M IPO with a PhIII contender. Article

> Bristol-Myers flags early success for PhIII Opdivo study in kidney cancer. Report

Animal Health News

> KC Animal Health Corridor investment forum slated for early September. More

> Aratana charts positive results for canine pain drug, predicts 2016 launch. Report

> PetCure spots booming market for radiosurgery in pets with cancer. Story

> Valeant steps into animal health with $800M acquisition of Egypt's Amoun. Article

> Virbac charts strong sales growth, nabs Big Pharma veteran to oversee quality. Item

Biotech IT News

> FDA turns to Google for help spotting adverse events. Report

> Vermillion raises $18.8M to fund escalation of bioinformatics ambitions. News

> Illumina wraps lab automation and software around HiSeq X to lower barrier to mass sequencing. Article

> Report: Danaher nears $30M buyout of computer-aided imaging business. More

> Arivale sets up with $36M, A-list founders and one eye on the R&D potential of its 'dense data clouds.' Story

Pharma Marketing News

> Does high TV ad rotation give patients the wrong idea about drugs? More

> Opdivo trial stopped early as BMS med tops Afinitor in kidney cancer. Item

> AstraZeneca ponies up for heart-attack patients with new Vida Health app. Report

> VC to pharma: Better get on board with digital health marketing. Story

> Lilly adds new Coco the Type 1 monkey tale to its Disney bookshelf. Article

And Finally... Did an early push to add HPV shots to the mandatory vaccinations list end up backfiring on the products? Report